Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342494 · ClinicalTrials.gov registry record · NA
Providing Mental Health Precision Treatment
A NA study of Depression and Anxiety, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 2,118
- Enrollment target
- 1
- Study location
NCT04342494: Completed NA study of Depression and Anxiety, sponsored by University of Michigan.
NCT04342494 is a NA study of Depression and Anxiety that has completed, run by University of Michigan. The registered enrollment target is 2,118 participants, above the 783-participant average among 679 other Depression trials with a reported enrollment target (170% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04342494, a NA study of Depression and Anxiety, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,118 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is being conducted to understand if patients benefit from mobile health interventions while waiting for in-clinic mental health treatments, and to understand which patients receive the most benefit.
Primary Outcome
The PHQ-9 was a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression. The PHQ-9 incorporated self-report questions on 9 specific depression symptoms that align with the DSM-IV depression diagnostic criteria. PHQ-9 scores ranged from 0-27, with 0 indicating no depression and 27 indicating severe depression.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Feedback + Standard Feedback
- DEVICE Headspace app + Standard Feedback
- DEVICE Headspace app + Enhanced Feedback + Standard Feedback
- DEVICE SilverCloud + Standard Feedback
- DEVICE SilverCloud app +Enhanced Feedback +Standard Feedback
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,118 participants |
| Start Date | 2020-05-13 |
| Est. Completion | 2023-02-22 |
| Phase | NA |
What the finished NCT04342494 record still lists
NCT04342494 is an interventional study that assigns participants to a tested intervention. Its 2,118 participants enrollment target places it among the larger protocols in the corpus, above the 783-participant average among 679 other Depression trials with a reported enrollment target (170% higher).
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 5 interventions - of which Enhanced Feedback + Standard Feedback is the first listed.
NCT04342494 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04342494 about?
NCT04342494 is a clinical study titled "Providing Mental Health Precision Treatment". This research study is being conducted to understand if patients benefit from mobile health interventions while waiting for in-clinic mental health treatments, and to understand which patients receive the most benefit.
What is the current status of trial NCT04342494?
This trial is currently completed. It is a NA study. The enrollment target is 2,118 participants. The study started on 2020-05-13. Estimated completion is 2023-02-22.
What conditions does trial NCT04342494 study?
This clinical trial studies the following conditions: Depression, Anxiety, Sleep Disturbance, Addiction.
What interventions are being tested in trial NCT04342494?
The interventions under investigation include: Enhanced Feedback + Standard Feedback (BEHAVIORAL), Headspace app + Standard Feedback (DEVICE), Headspace app + Enhanced Feedback + Standard Feedback (DEVICE), SilverCloud + Standard Feedback (DEVICE), SilverCloud app +Enhanced Feedback +Standard Feedback (DEVICE).
Who is sponsoring clinical trial NCT04342494?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04342494 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04342494's enrollment target sits among peer trials
2,118 24th of 679 higher than 656 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05916430 · 2,120 participants
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
- NCT05681624 · 2,124 participants · NA
Maternal Oxygen Supplementation for Intrauterine Resuscitation
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- NCT05967273 · 2,106 participants · NA
CirrhosisRx CDS System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy